Central Nervous System Modeling with iPSC-Derived Cells

Bryan Black and Lucas Thal will discuss their experiences screening hiPSC-derived neural cells to understand chronic pain and neuroinflammation.

The Creative Services Team in collaboration with BrainXell
Jun 8, 2021

FREE Webinar

Tuesday, July 20, 2021
2:30 - 4:00 PM, Eastern Time

Register Now

Neural cells differentiated from human induced pluripotent stem cells (hiPSCs) provide researchers with the opportunity to study processes that otherwise lack physiologically relevant models. Additionally, high-throughput phenotypic screening of hiPSC-derived cells promises to reduce the need for pre-clinical screening and improve drug discovery and development. In this webinar brought to you by BrainXell, Bryan Black and Lucas Thal will discuss their work screening hiPSC-derived neurons and microglia and the benefits of modeling the central nervous system with hiPSCs.

Topics to be covered

  • Primary and hiPSC support cell-enriched co-cultures in developing phenotypic assays
  • A high-content phenotypic assay for modulating neuroinflammatory processes in human iPSC-derived microglia

Register Now

Meet the Speakers:

Bryan James Black, PhD
Assistant Professor, Biomedical Engineering
Francis College of Engineering
University of Massachusetts


Lucas Thal, PhD
Scientist II
PhenoVista Biosciences



Sponsored by